Anti-Mullerian Hormone (AMH), Female
Test Summary
AMH-MIS may be used in the investigation of ovarian reserve since AMH concentrations in adult women reflect the number of small antral and preantral follicles entering the growth phase of their life cycle. These follicles are proportional to the number of primordial follicles that still remain in the ovary, or the ovarian reserve.
AMH decreases throughout a woman's reproductive life, which reflects the continuous decline of the oocyte/follicle pool with age and, accordingly, ovarian aging.
Aliases
- N/A
Specimen Collection
Special Instructions
N/A
Preferred Specimen
0.5 mL serum
Minimum Volume
0.3 mL
Instructions
Separate serum/plasma from the cells within 2 hours of collection, ship in a plastic leak-proof container refrigerated or frozen.
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Patient Preparation
N/A
Storage
Plastic transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 24 hours
- Refrigerated: 6 days
- Frozen: 28 days
Limitations
N/A
Other Acceptable Specimens
Plasma collected in a lithium heparin (green-top) tube
Unacceptable Specimens
Hemolysis • Lipemia • Received room temperature
Order Code
AMH
EPIC (Premier) Code
LAB6055
Includes
N/A
CPT Code
- 82166
Billing Code
- 670546
CPT Statement
Methodology
Immunoassay (IA)
FDA Status
FDA Approved
Physician Attestation of Informed Consent
N/A
Testing Laboratory
Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675
33608 Ortega Highway
San Juan Capistrano CA, 92675
Department
Reference Testing
Reference Range
| 0-17 years | Not established |
| 18-25 years | 1.02 -14.63 ng/mL |
| 26-30 years | 0.69-13.39 ng/mL |
| 31-35 years | 0.36-10.07 ng/mL |
| 36-40 years | 0.18-5.68 ng/mL |
| 41-45 years | 0.01-2.99 ng/mL |
| >45 years | Not established |
Setup Schedule / Expected Turnaround Time
Monday - Saturday; Report available: 2 - 3 days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
0.5 mL serum
Minimum Volume
0.3 mL
Instructions
Separate serum/plasma from the cells within 2 hours of collection, ship in a plastic leak-proof container refrigerated or frozen.
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Patient Preparation
N/A
Storage
Plastic transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 24 hours
- Refrigerated: 6 days
- Frozen: 28 days
Limitations
N/A
Other Acceptable Specimens
Plasma collected in a lithium heparin (green-top) tube
Unacceptable Specimens
Hemolysis • Lipemia • Received room temperature
Result Information
Methodology
Immunoassay (IA)
Testing Laboratory
N/A
Reference Range
| 0-17 years | Not established |
| 18-25 years | 1.02 -14.63 ng/mL |
| 26-30 years | 0.69-13.39 ng/mL |
| 31-35 years | 0.36-10.07 ng/mL |
| 36-40 years | 0.18-5.68 ng/mL |
| 41-45 years | 0.01-2.99 ng/mL |
| >45 years | Not established |
Setup Schedule / Expected Turnaround Time
Monday - Saturday; Report available: 2 - 3 days